Vanguard Group Inc Ligand Pharmaceuticals Inc Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,076,283 shares of LGND stock, worth $417 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,076,283

Previous 2,089,371 0.63%

Holding current value

$417 Million

Previous $238 Million 54.85%

% of portfolio

0.01%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$112.56 - $177.14 $1.47 Million - $2.32 Million	-13,088 Reduced 0.63%	2,076,283 $368 Million
Q2 2025 Aug 11, 2025	BUY	$96.67 - $118.22 $3.25 Million - $3.98 Million	33,639 Added 1.64%	2,089,371 $238 Million
Q1 2025 May 09, 2025	SELL	$105.14 - $122.23 $3.14 Million - $3.65 Million	-29,895 Reduced 1.43%	2,055,732 $216 Million
Q4 2024 Feb 11, 2025	BUY	$99.95 - $129.9 $11.5 Million - $14.9 Million	115,005 Added 5.84%	2,085,627 $223 Million
Q3 2024 Nov 13, 2024	BUY	$82.7 - $110.11 $3.62 Million - $4.82 Million	43,748 Added 2.27%	1,970,622 $197 Million

Q2 2024 Aug 13, 2024	BUY	$68.53 - $87.91 $2.93 Million - $3.76 Million	42,762 Added 2.27%	1,926,874 $162 Million
Q1 2024 May 10, 2024	BUY	$68.64 - $89.2 $521,526 - $677,741	7,598 Added 0.4%	1,884,112 $138 Million
Q4 2023 Feb 14, 2024	BUY	$49.57 - $72.63 $1.22 Million - $1.79 Million	24,653 Added 1.33%	1,876,514 $134 Million
Q3 2023 Nov 14, 2023	SELL	$58.86 - $72.67 $87,819 - $108,423	-1,492 Reduced 0.08%	1,851,861 $111 Million
Q2 2023 Aug 14, 2023	SELL	$69.53 - $79.33 $365,797 - $417,355	-5,261 Reduced 0.28%	1,853,353 $134 Million
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $1.02 Million - $1.19 Million	15,499 Added 0.84%	1,858,614 $137 Million
Q4 2022 Feb 10, 2023	BUY	$61.72 - $96.74 $3.07 Million - $4.81 Million	49,701 Added 2.77%	1,843,115 $123 Million
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $194 - $2.09 Million	19,440 Added 1.1%	1,793,414 $154 Million
Q2 2022 Aug 12, 2022	BUY	$74.52 - $117.06 $3.45 Million - $5.42 Million	46,336 Added 2.68%	1,773,974 $158 Million
Q1 2022 May 13, 2022	BUY	$94.99 - $151.56 $1.04 Million - $1.65 Million	10,903 Added 0.64%	1,727,638 $194 Million
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $709,445 - $921,462	-5,556 Reduced 0.32%	1,716,735 $265 Million
Q3 2021 Nov 12, 2021	BUY	$102.33 - $144.73 $20.3 Million - $28.7 Million	198,136 Added 13.0%	1,722,291 $240 Million
Q2 2021 Aug 13, 2021	BUY	$113.03 - $155.64 $172 Million - $237 Million	1,524,155 New	1,524,155 $200 Million

Others Institutions Holding LGND

# of Institutions

342

Shares Held

20.5M

Call Options Held

19K

Put Options Held

11.5K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $3.39B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Ligand Pharmaceuticals Inc Transaction History